Jaundice is an almost universal phenomenon in the newborn, affecting 60% of babies in the first week of life. Current pathways for testing and treatment require admission to neonatal units which currently accounts 6% of all admissions. Improved point of care testing will support diagnosis and treatment at home.

Supported by the Chief Scientist Office and Hi, up to £220,000 is currently available for organisations to solve this challenge

Help us develop revolutionary technology for babies with major heart conditions to enable them to be safely monitored at home.
‍
More than 6,000 babies are born in the UK each year with major heart defects, also called congenital heart disease (CHD). Sadly, CHD is also the leading cause of infant death, ranking 6th globally.

In the UK epileptic seizures affect 1 in 100 people, and neurodevelopment problems including cerebral palsy affect 1 in every 400 babies.

Accurate diagnosis can be challenging and up to 30% of people with epilepsy may have a late or wrong diagnosis. Delayed or inappropriate treatment can in the most severe cases can also lead to irreversible brain damage.

The Royal Hospital for Children’s has more than 180,000 clinical interactions each year, and more than 70,000 patients attending our site across 27 specialties and departments.

Our busy clinical teams need faster access to patient information to allow more rapid decision-making for the best possible care.